[English] 日本語
Yorodumi- PDB-2l4k: Water refined solution structure of the human Grb7-SH2 domain in ... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 2l4k | ||||||
|---|---|---|---|---|---|---|---|
| Title | Water refined solution structure of the human Grb7-SH2 domain in complex with the 10 amino acid peptide pY1139 | ||||||
Components |
| ||||||
Keywords | SIGNALING PROTEIN / Grb7 / SH2 domain / erbB2 receptor / water refinement | ||||||
| Function / homology | Function and homology informationnegative regulation of immature T cell proliferation in thymus / ERBB3:ERBB2 complex / ERBB2-ERBB4 signaling pathway / GRB7 events in ERBB2 signaling / RNA polymerase I core binding / immature T cell proliferation in thymus / semaphorin receptor complex / ErbB-3 class receptor binding / motor neuron axon guidance / Sema4D induced cell migration and growth-cone collapse ...negative regulation of immature T cell proliferation in thymus / ERBB3:ERBB2 complex / ERBB2-ERBB4 signaling pathway / GRB7 events in ERBB2 signaling / RNA polymerase I core binding / immature T cell proliferation in thymus / semaphorin receptor complex / ErbB-3 class receptor binding / motor neuron axon guidance / Sema4D induced cell migration and growth-cone collapse / regulation of microtubule-based process / RND1 GTPase cycle / PLCG1 events in ERBB2 signaling / ERBB2-EGFR signaling pathway / neurotransmitter receptor localization to postsynaptic specialization membrane / enzyme-linked receptor protein signaling pathway / ERBB2 Activates PTK6 Signaling / neuromuscular junction development / ERBB2-ERBB3 signaling pathway / Drug-mediated inhibition of ERBB2 signaling / Resistance of ERBB2 KD mutants to trastuzumab / Resistance of ERBB2 KD mutants to sapitinib / Resistance of ERBB2 KD mutants to tesevatinib / Resistance of ERBB2 KD mutants to neratinib / Resistance of ERBB2 KD mutants to osimertinib / Resistance of ERBB2 KD mutants to afatinib / Resistance of ERBB2 KD mutants to AEE788 / Resistance of ERBB2 KD mutants to lapatinib / Drug resistance in ERBB2 TMD/JMD mutants / positive regulation of Rho protein signal transduction / positive regulation of MAP kinase activity / positive regulation of transcription by RNA polymerase I / ERBB2 Regulates Cell Motility / semaphorin-plexin signaling pathway / oligodendrocyte differentiation / RET signaling / PI3K events in ERBB2 signaling / positive regulation of protein targeting to membrane / regulation of angiogenesis / regulation of ERK1 and ERK2 cascade / Schwann cell development / coreceptor activity / Tie2 Signaling / Signaling by ERBB2 / TFAP2 (AP-2) family regulates transcription of growth factors and their receptors / myelination / transmembrane receptor protein tyrosine kinase activity / phosphatidylinositol binding / stress granule assembly / Downstream signal transduction / GRB2 events in ERBB2 signaling / positive regulation of cell adhesion / SHC1 events in ERBB2 signaling / cell surface receptor protein tyrosine kinase signaling pathway / Downregulation of ERBB2:ERBB3 signaling / basal plasma membrane / peptidyl-tyrosine phosphorylation / Constitutive Signaling by Overexpressed ERBB2 / cellular response to epidermal growth factor stimulus / positive regulation of translation / positive regulation of epithelial cell proliferation / cell projection / neuromuscular junction / phosphatidylinositol 3-kinase/protein kinase B signal transduction / wound healing / Signaling by ERBB2 TMD/JMD mutants / Signaling by SCF-KIT / receptor protein-tyrosine kinase / Signaling by ERBB2 ECD mutants / receptor tyrosine kinase binding / Signaling by ERBB2 KD Mutants / cellular response to growth factor stimulus / ruffle membrane / Downregulation of ERBB2 signaling / epidermal growth factor receptor signaling pathway / neuron differentiation / cytoplasmic stress granule / Constitutive Signaling by Aberrant PI3K in Cancer / transmembrane signaling receptor activity / PIP3 activates AKT signaling / myelin sheath / heart development / presynaptic membrane / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / RAF/MAP kinase cascade / positive regulation of cell growth / protein tyrosine kinase activity / basolateral plasma membrane / early endosome / cell surface receptor signaling pathway / cell population proliferation / protein phosphorylation / receptor complex / positive regulation of MAPK cascade / endosome membrane / negative regulation of translation / intracellular signal transduction / positive regulation of cell migration / apical plasma membrane / protein heterodimerization activity Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | SOLUTION NMR / molecular dynamics simulated annealing, simulated annealing | ||||||
| Model details | best PROCHECK statistics, model 3 | ||||||
Authors | Pias, S.C. / Ivancic, M. / Brescia, P.J. / Johnson, D.L. / Smith, D.E. / Daly, R.J. / Lyons, B.A. | ||||||
Citation | Journal: Protein Pept.Lett. / Year: 2012Title: Water-Refined Solution Structure of the Human Grb7-SH2 Domain in Complex with the erbB2 Receptor Peptide pY1139. Authors: Pias, S.C. / Johnson, D.L. / Smith, D.E. / Lyons, B.A. #1: Journal: J.Biomol.Nmr / Year: 2003Title: Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2. Authors: Ivancic, M. / Daly, R.J. / Lyons, B.A. #2: Journal: J.Biomol.Nmr / Year: 2002 Title: Assignment of backbone 1H, 13C, and 15N resonances of human Grb7-SH2 domain in complex with a phosphorylated peptide ligand. Authors: Brescia, P.J. / Ivancic, M. / Lyons, B.A. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 2l4k.cif.gz | 418.7 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb2l4k.ent.gz | 344.5 KB | Display | PDB format |
| PDBx/mmJSON format | 2l4k.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 2l4k_validation.pdf.gz | 374 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 2l4k_full_validation.pdf.gz | 476.4 KB | Display | |
| Data in XML | 2l4k_validation.xml.gz | 23.8 KB | Display | |
| Data in CIF | 2l4k_validation.cif.gz | 39.6 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/l4/2l4k ftp://data.pdbj.org/pub/pdb/validation_reports/l4/2l4k | HTTPS FTP |
-Related structure data
| Related structure data | |
|---|---|
| Similar structure data | |
| Other databases |
|
-
Links
-
Assembly
| Deposited unit | ![]()
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| |||||||||
| NMR ensembles |
| |||||||||
| Details | THE DIMERIC ANNOTATION IN REMARK 350 REFERS TO THE TWO CHAINS OF THE ASSEMBLY (PROTEIN DOMAIN AND LIGAND) |
-
Components
| #1: Protein | Mass: 13690.711 Da / Num. of mol.: 1 / Fragment: unp residues 415-532 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: GRB7 / Plasmid: pGEX-2T / Production host: ![]() |
|---|---|
| #2: Protein/peptide | Mass: 1266.205 Da / Num. of mol.: 1 / Fragment: unp residues 1135-1144 / Source method: obtained synthetically / Source: (synth.) Homo sapiens (human)References: UniProt: P04626, receptor protein-tyrosine kinase |
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: SOLUTION NMR | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NMR experiment |
|
-
Sample preparation
| Details | Contents: 0.6-0.8 mM [U-100% 13C; U-100% 15N] Grb7-SH2 domain-1, 0.6-0.8 mM [U-100% 13C; U-100% 15N] pY1139 peptide-2, 52.2 mM acetic acid-3, 100 mM sodium chloride-4, 5 mM DTT-5, 1 mM EDTA-6, 0.9 mM ...Contents: 0.6-0.8 mM [U-100% 13C; U-100% 15N] Grb7-SH2 domain-1, 0.6-0.8 mM [U-100% 13C; U-100% 15N] pY1139 peptide-2, 52.2 mM acetic acid-3, 100 mM sodium chloride-4, 5 mM DTT-5, 1 mM EDTA-6, 0.9 mM sodium azide-7, 90% H2O/10% D2O Solvent system: 90% H2O/10% D2O | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample |
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Sample conditions | pH: 6.6 / Pressure: ambient / Temperature: 298 K |
-NMR measurement
| NMR spectrometer | Type: Varian INOVA / Manufacturer: Varian / Model: INOVA / Field strength: 500 MHz |
|---|
-
Processing
| NMR software |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method: molecular dynamics simulated annealing, simulated annealing Software ordinal: 1 Details: Refinement with AMBER software, using implicit water (generalized Born model) and ff99SB force field, Structure calculation with CNS software, in vacuum | ||||||||||||
| NMR representative | Selection criteria: best procheck statistics | ||||||||||||
| NMR ensemble | Conformer selection criteria: structures with the lowest energy and the fewest restraint violations Conformers calculated total number: 50 / Conformers submitted total number: 10 |
Movie
Controller
About Yorodumi



Homo sapiens (human)
Citation









PDBj













HNCA